Background: Researchers at the Food and Drug Administration (FDA)/Center for Device and Radiological Health/Office of Science and Engineering Laboratories have been exploring the concept of model-based engineering as a means for improving the quality of medical device software. Insulin pumps were chosen as a research subject because their design provides the desired degree of research complexity and these types of devices present an ongoing regulatory challenge. Methods: Insulin pump hazards and their contributing factors are considered in the context of a highly abstract generic insulin infusion pump (GIIP) model. Hazards were identified by consulting with manufacturers, pump users, and clinicians; by reviewing national and international standards and adverse event reports collected by the FDA; and from workshops sponsored by Diabetes Technology Society. This information has been consolidated in tabular form to facilitate further community analysis and discussion. Results: A generic insulin infusion pump model architecture has been established. A fairly comprehensive hazard analysis document, corresponding to the GIIP model, is presented in this article. Conclusions: We believe that this work represents the genesis of an insulin pump safety reference standard upon which future insulin pump designs can be based to help ensure a basic level of safety. More interaction with the diabetes community is needed to assure the quality of this safety modeling process.
8 July 2013 in IEEE Antennas and Wireless Propagation Letters
This letter presents a novel design of patch antenna with quasi-cross-slot and capacitive coupling feeding to achieve tripolarization with high isolation over a wide bandwidth. Two degenerate TM11 modes and one TM01 mode of the circular patch antenna are generated to realize three orthogonal polarizations. By using the proposed quasi-cross-slots, good measured isolations (better than 20 dB) were obtained. The measured impedance bandwidths of the proposed antenna ports are 2.13-2.58, 2.13-2.43, and 2.13-2.58 GHz, respectively. Details of the proposed design and measured results are presented and discussed.
8 May 2019 in IEEE Transactions on Biomedical Engineering
Objective: This paper presents a hardware-in-the-loop (HIL) testing platform for evaluating the performance of fluid resuscitation control algorithms. The proposed platform is a cyber-physical system that integrates physical devices with computational models and computer-based algorithms. Methods: The HIL test bed is evaluated against in silico and in vivo data to ensure the hemodynamic variables are appropriately predicted in the proposed platform. The test bed is then used to investigate the performance of two fluid resuscitation control algorithms: a decision table (rule-based) and a proportional-integral-derivative (PID) controller. Results: The statistical evaluation of test bed indicates that similar results are observed in the HIL test bed, in silico implementation, and the in vivo data, verifying that the HIL test bed can adequately predict the hemodynamic responses. Comparison of the two fluid resuscitation controllers reveals that both controllers stabilized hemodynamic variables over time and had similar speed to efficiently achieve the target level of the hemodynamic endpoint. However, the accuracy of the PID controller was higher than the rule-based for the scenarios tested in the HIL platform. Conclusion: The results demonstrate the potential of the HIL test bed for realistic testing of physiologic controllers by incorporating physical devices with computational models of physiology and disturbances. Significance: This type of testing enables relatively fast evaluation of physiologic closed-loop control systems to aid in iterative design processes and offers complementary means to existing techniques (e.g., in silico, in vivo, and clinical studies) for testing of such systems against a wide range of disturbances and scenarios.
Background: The authors previously introduced a highly abstract generic insulin infusion pump (GIIP) model that identified common features and hazards shared by most insulin pumps on the market. The aim of this article is to extend our previous work on the GIIP model by articulating safety requirements that address the identified GIIP hazards. These safety requirements can be validated by manufacturers, and may ultimately serve as a safety reference for insulin pump software. Together, these two publications can serve as a basis for discussing insulin pump safety in the diabetes community. Method: In our previous work, we established a generic insulin pump architecture that abstracts functions common to many insulin pumps currently on the market and near-future pump designs. We then carried out a preliminary hazard analysis based on this architecture that included consultations with many domain experts. Further consultation with domain experts resulted in the safety requirements used in the modeling work presented in this article. Results: Generic safety requirements for the GIIP model are presented, as appropriate, in parameterized format to accommodate clinical practices or specific insulin pump criteria important to safe device performance. Conclusion: We believe that there is considerable value in having the diabetes, academic, and manufacturing communities consider and discuss these generic safety requirements. We hope that the communities will extend and revise them, make them more representative and comprehensive, experiment with them, and use them as a means for assessing the safety of insulin pump software designs. One potential use of these requirements is to integrate them into model-based engineering (MBE) software development methods. We believe, based on our experiences, that implementing safety requirements using MBE methods holds promise in reducing design/implementation flaws in insulin pump development and evolutionary processes, therefore improving overall safety of insulin pump software.
1 January 2017 in Journal of Korean Medical Science